Germany· DE-A57-3fc8bd87b262caec
Tianeurax
A tianeptine product containing tianeptine sodium, registered in Germany by Neuraxpharm Arzneimittel Gmbh. The same ATC class is registered in 5 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Tianeptine is registered in 5 of 19 countries.
Countries holding a registration under ATC N06AX14 (tianeptine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 4 of them publish a price we can compare per daily dose
Tianeptine · ATC N06AX14
5 / 19 countries
- Czechiaprice
- Franceprice
- Germany
- Norwayprice
- Polandprice
Price per daily dose
What a daily dose of tianeptine costs, country by country.
Normalised to the WHO defined daily dose (37.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tianeptine · price per daily dose (37.5 mg)
USD · FX 28 Sept 2026
- FR France$0.36
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Tianeptine Sodium
- Manufacturer
- Neuraxpharm Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- N06AX14
- ATC class
- Tianeptine
- Defined daily dose
- 37.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tianeptine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAtinepteZakłady Farmaceutyczne POLPHARMA S.A.
- FranceSTABLON 12,5 mg, comprimé enrobéLES LABORATOIRES SERVIER
- CzechiaCOAXILLes Laboratoires Servier, Suresnes cedex
- SpainZINOSAL 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGExeltis Healthcare S.L.
- NorwayTianeuraxNeuraxpharm
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Stablon
- Bulgaria · Коаксил
- Czechia · Coaxil
- Estonia · Coaxil, Salymbra
- Spain · Zinosal
- France · Stablon, Tianeptine Biogaran
- Greece · Tianeptine Liconsa
- Croatia · Coaxil, Neptika
- Hungary · Aneptinex, Coaxil
- Lithuania · Coaxil
- Luxembourg · Stablon
- Latvia · Coaxil
- Poland · Atinepte, Coaxil
- Portugal · Neluptin, Stablon
- Romania · Coaxil, Lyxit
- Slovenia · Coaxil
- Slovakia · Aneptinex, Coaxil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7c2b6e02-6776-4a98-8c9d-ca2c67245082 GET /v1/drugs/7c2b6e02-6776-4a98-8c9d-ca2c67245082?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Tianeptine Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about tianeptine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.